[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@keisan_15 Kさん
Kさん posts on X about $tngx, $rvmd, to the, $fro the most. They currently have XX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXX +189%
- X Month XXXXX -XX%
- X Months XXXXXX +8,195%
- X Year XXXXXX +3,980%
Mentions: X #
Followers: XX #
- X Week XX +1.20%
- X Month XX +6.40%
- X Months XX +152%
CreatorRank: undefined #
Social Influence
Social category influence finance XXXXX% stocks XXXX%
Social topic influence $tngx #7, $rvmd 16.67%, to the 8.33%, $fro 8.33%, multiplier 8.33%, $psnl 8.33%, cash flow 8.33%, flow 8.33%, $gral 8.33%, guess XXXX%
Top accounts mentioned or mentioned by @bananaoncology @houndcl @semodough @augurbio @midwitcapital @banana_oncology @midwit_capital
Top assets mentioned Revolution Medicines, Inc. Common Stock (RVMD) Frontline Ltd. (FRO) GRAIL, Inc. Common Stock (GRAL)
Top Social Posts
Top posts by engagements in the last XX hours
"$TNGX Research Director Adam Crystal today: "Pancreatic cancer is fortunately changing very quickly for patientsKRAS inhibitors will likely be approved next year Daraxonrasib specifically in the second line. And we believe that it will quickly advance to the front-line"
X Link 2025-12-03T23:15Z XX followers, XXX engagements
"@semodough PCVX isn't at JPM.does this mean imminent b/o by Pfizer 😱 But honestly the stock looks good despite the current vaccine headwinds"
X Link 2025-12-10T11:52Z XX followers, XX engagements
"Better Sensitivity table. Forgot to change some numbers. Think of the left $1150 column representing a baseline where reimbursement is medicare only. Right gets to a more normal commercial reimbursement mix (1.4x premium multiplier). Again DCF so a conservative valuation"
X Link 2025-12-02T02:53Z XX followers, XXX engagements
"Basically if $PSNL ever dipped below $7-9 (depending on your conviction) I'd buy buy buy today. Price point goes higher as you get more confirmation of the volume and cash flow story through '26/'27"
X Link 2025-12-03T15:40Z XX followers, XXX engagements
"But how does $GRAL change the story and competitive space if it gets into MRD Should we be worried"
X Link 2025-12-03T15:41Z XX followers, XXX engagements
"In other news $TNGX fireside chat today at Piper HC conferece 1:30 et"
X Link 2025-12-03T15:58Z XX followers, XXX engagements
"Initial takeaway from the $TNGX chat: they love $RVMD"
X Link 2025-12-03T18:57Z XX followers, XXX engagements
"$RVMD $TNGX TNG462/RMC-6236 Combo PDAC Trial PoS: ORR XX% - 30-40% PoS ORR XX% - XX% PoS mPFS 10mo - XX% PoS Agree Disagree Way too optimistic"
X Link 2025-12-04T22:02Z XX followers, XXX engagements
"@midwit_capital @houndcl Yeah I guess I'm just looking for input from @Banana_Oncology (and others) on the acquisition in terms of Signatera vs NeXT. Again with the overall TAM and esp with Tempus' existing base lots of runway still for PSNL. And the royalty is nice"
X Link 2025-12-05T17:15Z XX followers, XXX engagements